This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
JPMorgan Chase & Co (NYSE: JPM) came in with some bullish numbers this morning, with revenue up 18% for the most recent quarter. Not all the big banks were as bullish, but it does show that the financial sector is finally finding a way to make money more consistently without relying on the risky derivatives market.
PZBW LOB JPM BCML NRZ HLNE VIRT IBKR SIVB ENVA CIGI
NEW YORK, July 05, 2018 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a technology enabled global market maker, will announce its results for the second quarter 2018 on Friday, July 27th, 2018 before the U.S. market opens. Virtu will host a conference call to discuss the company's financial results at 8:00 a.m. Eastern Time (ET).
New Concept Energy, Inc. (AMEX:GBR) has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 79,523 shares. Largest shareholders include Price T Rowe Associates Inc /md/, Vanguard Group Inc, Virtu Financial LLC, and UBS Group AG. New Concept Energy, Inc. (AMEX:GBR) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.
UBS VIRT MRTX GBR UBS.PRDCL ULSGF
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MS.PRI UBS MS.PRK VIRT MS.PRE UBS.PRDCL MS.PRF MS.PRG MS MS.PRA KCG ULSGF
Appliance Recycling Centers of America, Inc. (NASDAQ:ARCI) has 13 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 374,375 shares. Largest shareholders include Renaissance Technologies LLC, Perkins Capital Management Inc, Panagora Asset Management Inc, Susquehanna International Group, Llp, Virtu Financial LLC, First Wilshire Securities Management Inc, Bank of New York Mellon Corp, Captrust Financial Advisors, UBS Group AG, and BlackRock Inc.
PRTO BLK UBS VIRT UBS.PRDCL GALPW GALE STML ARCI ULSGF GALEW
ReWalk Robotics Ltd (NASDAQ:RWLK) has 24 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,308,359 shares. Largest shareholders include Timwell Corp Ltd, SCP Vitalife Partners II LP, Advisor Group, Inc., California Public Employees Retirement System, Virtu Financial LLC, Intellectus Partners, LLC, Rosenbaum Jay D.
BABA VIRT RWLK FH KANG XSPA
Stocks were up earlier this week, but fresh warnings that a North Korea summit might not actually happen in June weighed on the indexes on Wednesday. The trend of buying the dips has not worked as well as it has in prior years, and many investors have been considering how they want their investments positioned for the longer term.
RIO CY RIO KOOL MS.PRE MS.PRF MS.PRG MS.PRA KOOLW AEE RTPPF EL SHAK CELG RTNTF MS VNRX CSCWF CELGZ WLL KMPH INTU OAS MS.PRI RIO MS.PRK VIRT TRI
It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though there are some hidden gems that could be worth uncovering by those with a high risk tolerance.
In its concerted efforts to increase shareholder value, the board of directors of Synchrony Financial (SYF - Free Report) has announced a plan to hike the quarterly dividend by 94%, effective third-quarter 2018. The company would pay a dividend of 21 cents per share to shareholders of record as of Mar 31, 2018.
VIRT SYF CGBD
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to VIRT / Virtu Financial, Inc. on message board site Silicon Investor.
as of ET